Results also showed that staff who were vitamin D deficient were more likely to report symptoms of body aches and pains, but interestingly, not respiratory symptoms including breathlessness or a continuous cough. Vitamin levels were also lower in staff who reported symptoms of fever. Within the cohort as a whole, there was an increase in seroconversion (or the development of detectable SARS-Cov-2 antibodies) in staff with vitamin D deficiency (72%) compared to those without a deficiency (51%) suggesting that lower vitamin D levels could increase susceptibility to the virus. This was particularly prevalent in the proportion of BAME males who were vitamin D deficient (94%) compared to non-vitamin D deficient BAME males (52%).
Author Professor David Thickett, from the University of Birmingham’s Institute of Inflammation and Ageing, said: “Our study has shown that there is an increased risk of COVID-19 infection in healthcare workers who are deficient in vitamin D. Our data adds to the emerging evidence from studies in the UK and globally that individuals with severe COVID-19 are more vitamin D deficient than those with mild disease. Finally, our results, combined with existing evidence further demonstrates the potential benefits of vitamin D supplementation in individuals at risk of vitamin D deficiency or who are shown to be deficient as a way to potentially alleviate the impact of COVID-19.”